CKD Bio Corp. (KRX:063160)
South Korea · Delayed Price · Currency is KRW 21,050
-350 (-1.64%)
At close: Nov 21, 2025
CKD Bio Market Cap
CKD Bio has a market cap or net worth of 114.93 billion as of November 26, 2025. Its market cap has decreased by -18.16% in one year.
Market Cap
114.93B
Enterprise Value
261.71B
Revenue
159.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
21,050.00
Market Cap Chart
Since March 1, 2002, CKD Bio's market cap has increased from 10.15B to 114.93B, an increase of 1,032.75%. That is a compound annual growth rate of 10.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 114.93B | -4.77% |
| Dec 30, 2024 | 120.69B | -7.76% |
| Dec 28, 2023 | 130.84B | 0.21% |
| Dec 29, 2022 | 130.57B | -43.06% |
| Dec 30, 2021 | 229.31B | -47.68% |
| Dec 30, 2020 | 438.33B | 175.88% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.81T |
| Celltrion | 39.84T |
| ALTEOGEN | 28.19T |
| SK Biopharmaceuticals | 9.91T |
| ABL Bio | 9.54T |
| Yuhan | 8.73T |
| Peptron | 8.60T |
| LigaChem Biosciences | 6.25T |